{"text": "TITLE:\n      A Neurocognitive and Immunological Study of a New Formula for Healthy Infants\nSUMMARY:\n      To compare the neurocognitive and immunological development in infants fed a new infant\n      formula with functional specific nutrients to infants consuming a standard infant formula.\nELIGIBILITY CRITERIA:\n      Inclusion Criteria:\n          -  Full-term newborns (>37 weeks and <41 weeks gestation)\n          -  Adequate birth weight for his gestational age (between 3-97 percentiles)\n          -  Inclusion age: from 0 to 2 months (60 days)\n          -  Maximum 30 days of exclusive breastfeeding\n          -  From 30 days on, exclusive or >70% infant formula\n          -  Normal Apgar score: 7-10\n          -  Umbilical pH \u2265 of 7.10\n          -  Availability to continue during the whole study period\n          -  Informed consent signed ( parent/legal representative)\n        Exclusion Criteria:\n          -  Participating in other studies.\n          -  Nervous system disorders (hydrocephalic, perinatal hypoxia, intraventricular\n             hemorrhage, neonatal meningitis, septic shock, West Sd...).\n          -  Gastrointestinal disorders (cow's milk protein allergy, lactose intolerance)\n          -  Mother's disease history or during pregnancy: neurological and metabolic diseases,\n             diabetes mellitus type 1, hypothyroidism, undernutrition, infections TORCH complex.\n          -  Mothers receiving anxiolytic or antidepressant treatment during pregnancy or other\n             potentially harmful drug treatments for infants' neurodevelopment.\n          -  Infant currently participating in another clinical study\n          -  Infant's family who in the investigators assessment cannot be expected to comply with\n             the protocol.\n", "cuis": "C0518895 C0489829 C1705501 C0720509 C1654724 C1659403 C1724072 C0947630 C1521740 C1552616 C1706244 C0518895 C0872227 C0243107 C0678723 C0020119 C3272564 C3151684 C1578513 C1552740 C0038137 C2828392 C3272550 C2363038 C2228127 C0031843 C0016590 C1553526 C0243161 C0013893 C0243161 C1135241 C1551035 C2239178 C2053598 C1148461 C0424653 C1305866 C2053618 C0005615 C1550722 C3245487 C3843731 C3842337 C0006147 C1623040 C1623041 C3842337 C2946875 C2363038 C2228127 C3842337 C0231683 C1550457 C1551394 C1873497 C0741195 C0041638 C0025344 C0947630 C0742766 C0742765 C0973449 C0243161 C0947630 C0027765 C1112140 C0574091 C0154725 C0559478 C1517569 C0264909 C0020255 C0456107 C0036983 C0019080 C0017181 C1861265 C0037769 C0017178 C0947846 C0021831 C0810300 C0810305 C0810319 C1112313 C0872176 C0022951 C0016952 C0860475 C1655220 C0016751 C0348485 C1112677 C0567447 C3889086 C0026131 C2702362 C2097391 C3496562 C0025517 C0683519 C0032961 C1391387 C3484365 C2707261 C3845870 C0237094 C0237133 C0237142 C0237155 C0237161 C0237162 C0237169 C0237178 C0237185 C0237206 C0237221 C0237228 C0237247 C0237255 C0237276 C0237283 C0237289 C0237305 C0237318 C0237324 C0237338 C0237357 C0237361 C0237369 C0237373 C0237380 C0237387 C1948167 C1948168 C1948169 C1948170 C1948171 C1948173 C1948174 C1948176 C1948178 C1948179 C1948180 C1948181 C0011854 C0271636 C0271637 C0011860 C0567407 C3837969 C3837972 C3837970 C3837971 C3837973 C3837974 C0020676 C0455486 C0162429 C3714514 C0009450 C0275524 C2707258 C0729555 C0747002 C0939261 C0003289 C2698157 C1741963 C0040616 C0087111 C3887704 C0376495 C1533734 C0746919 C0814472 C3647788 C0032961 C1391387 C3484365 C3539125 C0087111 C3887704 C0376495 C0814472 C0013227 C1254351 C0947630 C3272565 C0031809 C1261322 C0220825 C0870300 C1319010 C4055646 C1517001 C0442711 C1507394 C1522729 C2348563 C3715209 ", "concepts": "Neurocognitive, Formula, Formula, Formula B, Formula U, Formula M, L-Formula, Study, Immunologics summary, summary neurocognitive, neurocognitive test, development, Development, Development, Development, No development, new specific, standards, Standard, Standard, Infant formula, infant formula term, function, formulary, formulary criteria, Eligibility Criteria weeks gestation, newborn, newborn gestational age, Gestational age, weight, weight, weight, births, birth, birth 1 to 2 months, 0 days breastfeedings, Breastfeeding, Breastfeeding, 0 days, Maximum-H Infant formula, infant formula term, 0 days Normal, Normal, Normal, Normal, Apgar Umbilical period, study consent signed, consent not signed, galega Criteria studies Nervous system disorders NOS, Nervous system disorders NEC, FH: Nervous system disorder, Other nervous system disorders, perinatal hypoxia, Intraventricular, intraventricular block, hydrocephaly neonatal meningitis, septic shock, hemorrhage, GI hemorrhage, No hemorrhage, West Gastrointestinal disorder, NOS, Gastrointestinal disorders NEC, intestinal disorders, Upper gastrointestinal disorders, Lower gastrointestinal disorders, Other gastrointestinal disorders, Gastrointestinal mucosal disorder, Gastrointestinal disorder therapy, lactose; intolerance, Galactose intolerance, NOS, lactose intolerant, lactose intolerance test, Fructose intolerance, Other lactose intolerance, protein allergy, Egg protein allergy, Milk protein allergy, milk, milk, cow, cow metabolic diseases, disease history, pregnancy, c.pregnancy, Pregnancy, Neurological, ICU.neurological, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other, other Diabetes mellitus type I, diabetes mellitus type 1a, diabetes mellitus type 1b, Diabetes mellitus type 2, diabetes mellitus type 1 brittle, diabetes mellitus type 1 - IDDM5, diabetes mellitus type 1 - IDDM2, diabetes mellitus type 1 - IDDM22, diabetes mellitus type 1 - IDDM20, diabetes mellitus type 1 - IDDM12, diabetes mellitus type 1 - IDDM10, hypothyroidism, H/O: hypothyroidism, undernutrition, Infections, infection, Coinfections, Infections, gi infections, infections op, complex b antidepressant drug, Antidepressants, Antidepressant rx, anxiolytic, Treatment, treatment, Retreatment, Treatment, no treatment, co-treatment, maltreatment, pregnancy, c.pregnancy, Pregnancy, others treatment, treatment, Retreatments, co treatments, drug, drug study, Clinical Assessment, assessments, Assessment, Assessment, IQ assessment, Unexpected, Expected Protocol, Protocol, Protocol, Protocol, Protocol "}
